IL17A and irritable bowel syndrome: It has been found that quercetin exerts a therapeutic effect in IBD by regulating the structure of the intestinal flora, inhibiting the expression of proinflammatory factors, such as IL-17, TNF-α, IL-6, and increasing the expression of IL-10 [36].